Rosalind Advisors »

Rezolute shares owned by Rosalind Advisors

Quarter-by-quarter ownership of Rezolute (RZLT) shares owned by Rosalind Advisors from 13F filings

Historical chart of Rosalind Advisors investment in Rezolute

Tip: Access up to 7 years of quarterly data

All positions including Rezolute held by Rosalind Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rezolute by Rosalind Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $510k 200k 2.55

More positions owned by Rosalind Advisors

Myomo Com New (MYO)
Lyra Therapeutics (LYRA)
Mediwound Shs New (MDWD)
Optinose (OPTN)
Xeris Pharmaceuticals (XERS)
Compass Pathways Sponsored Ads (CMPS)
Cybin Ord (CYBN)
Abivax Sa Sponsored Ads (ABVX)
Miragen Therapeutics (VRDN)
Delcath Systems Com New (DCTH)
Profound Medical Corp Com New (PROF)
Verona Pharma Sponsored Ads (VRNA)
Clearside Biomedical (CLSD)
Outlook Therapeutics Com New
Kalvista Pharmaceuticals (KALV)

View all positions for Rosalind Advisors

Top funds holding Rezolute

Federated Investors
Vivo Capital
Nantahala Capital Management
Blackstone Group
Vanguard Group
Sphera Funds Management
Citadel Advisors
UBS Group
Rosalind Advisors
BVF
Millennium Management
Charles Schwab Investment Management
Royal Bank of Canada
Wells Fargo & Company
Jpmorgan Chase & Co

View all funds holding Rezolute